发明名称 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
摘要 The invention relates to a dengue virus tetravalent vaccine containing a common 30 nucleotide deletion (Δ30) in the 3′-untranslated region of the genome of dengue virus serotypes 1, 2, 3, and 4, or antigenic chimeric dengue viruses of serotypes 1, 2, 3, and 4.
申请公布号 US8075903(B2) 申请公布日期 2011.12.13
申请号 US20090398043 申请日期 2009.03.04
申请人 WHITEHEAD STEPHEN S.;MURPHY BRIAN R.;MARKOFF LEWIS;FALGOUT BARRY;BLANEY JOSEPH;HANLEY KATHRYN;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 发明人 WHITEHEAD STEPHEN S.;MURPHY BRIAN R.;MARKOFF LEWIS;FALGOUT BARRY;BLANEY JOSEPH;HANLEY KATHRYN
分类号 A61K39/295;C12N15/09;A61K;A61K31/7088;A61K38/00;A61K39/00;A61K39/12;A61K39/42;A61P31/14;C07H21/00;C07H21/04;C12N7/00;C12N7/04 主分类号 A61K39/295
代理机构 代理人
主权项
地址